RxDoctor Payments Data

John Fetting, MD

Medical Oncology · Lutherville, MDNPI 1013947126

Payments from drug & device makers

$12in general payments, 2019–2025

Across 1 payment — averaging $11.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$12

What the payments were for

  • Education$12100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Gilead1$12

How this compares

$12 in reported general payments places this provider in the 5th percentile of 180 medical oncology providers in Maryland.

See all medical oncology providers in Maryland

Medicare billing

Part B allowed, 2024
$523,152
Medicare patients
35
Services billed
22,641

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VerzenioAbemaciclib17$230,530
Anastrozole27$413
Dexamethasone12$299
Oxycodone Hcl13$226
Letrozole13$210
Lorazepam12$39
Omeprazole13$5

Paid to pharmacies, not to this prescriber.

Other medical oncology in Lutherville

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →